Supplier log in
Request for Proposals - Supply of Volatile Anaesthetics in New Zealand
Details
|
Tender Closed
|
|
| RFx ID : | 17045806 |
| Tender Name : | Request for Proposals - Supply of Volatile Anaesthetics in New Zealand |
| Reference # : | A820659 |
| Open Date : | Thursday, 10 December 2015 5:00 PM (Pacific/Auckland UTC+13:00) |
| Close Date : | Friday, 22 January 2016 4:00 PM (Pacific/Auckland UTC+13:00) |
| Tender Type : | Request for Proposals (RFP) |
| Tender Coverage : | Sole Agency [?] |
| Categories : |
|
| Regions: |
|
| Exemption Reason : | None |
| Required Pre-qualifications : | None |
| Contact : |
Andrew Park andrew.park@pharmac.govt.nz |
| Alternate Physical Delivery Address : | |
| Alternate Physical Fax Number : | |
| Agency Address : | |
IMPORTANT NOTE - Please note that the due date for proposals has been extended until Friday 22 January 2016.
PHARMAC invites proposals for the supply of volatile anaesthetics in New Zealand.
This request for proposals (RFP) letter incorporates the following schedules:
· Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
· Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
· Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
· Schedule 4 contains the RFP form in which you are to provide details of your proposal.
· Appendix 1 contains further market information on anaesthetic machines used by DHB Hospitals
If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) no later than 4.00 p.m. on 22 January 2016 (not 15 January 2016 as outlined in the RFP document).
If you have any questions about this RFP, please submit them via GETS.
This tender has been awarded to:
- Baxter Healthcare Limited
Further Award Information:
PHARMAC is pleased to announce the approval of a sole supply agreement with Baxter Healthcare Limited for the supply of volatile anaesthetics sevoflurane, desflurane and isoflurane which are used in DHB hospitals during general anaesthesia.
This was subject to a consultation letter dated 30 June 2016, available on www.pharmac.govt.nz. The proposal was approved as consulted on.
In summary, the effect of the decision is that from 1 September 2016 there will be:
• a reduction in price across all three volatile anaesthetics supplied by Baxter currently used in DHB Hospitals; and
• continued supply of loan vaporisers for the administration of sevoflurane, desflurane and isoflurane as required by DHB hospitals.
• Baxter’s Sevoflurane, Suprane and Aerrane will remain listed, in Part II of Section H of the Pharmaceutical Schedule at decreased prices from 1 September 2016.
• Hospital Supply Status will apply to the above three pharmaceuticals from 1 September 2016 until 30 June 2019 (the HSS Period) with a 1% DV limit.
• As indicated in the RFP document, the HSS Period for each pharmaceutical could be extended for an additional period of 12 or 24 months at PHARMACs discretion
Vaporisers
• Baxter will continue to provide and support a sufficient number of vaporisers on loan to DHB Hospitals for the administration of sevoflurane, desflurane and isoflurane as required in each DHB Hospital. The range of supported vaporiser models available on loan and specified in the agreement has been expanded to include new models manufactured by Dräger, GE and Maquet.
Award Date: Monday, 15 August 2016 (Pacific/Auckland UTC+12:00)
Date RFx was completed/updated: Tuesday, 26 January 2016 11:35 AM (Pacific/Auckland UTC+13:00)
